Biblio

33557 resultats trouvés
Filtres: Filter is   [Clear All Filters]
T
Simeon S., Le Moing V, Tubiana S., Duval X., Fournier D., Lavigne J-P, Erpelding M-L, Gustave C-A, Desage S., Chirouze C. et al..  2019.  Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia. CLINICAL MICROBIOLOGY AND INFECTION. 25:481-488.
Hamidou Z, Chibaudel B, Hebbar M, de Larauze MHug, Andre T, Louvet C, Brusquant D, Garcia-Larnicol M-L, de Gramont A, Bonnetain F.  2016.  Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial. PLOS ONE. 11:e0157067.
Charton E., Cuer B., Cottone F., Efficace F., Touraine C., Hamidou Z., Fiteni F., Bonnetain F., Woronoff-Lemsi M.-C, Bascoul-Mollevi C. et al..  2020.  Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review. QUALITY OF LIFE RESEARCH. 29:867-878.
Charton E., Cuer B., Cottone F., Efficace F., Touraine C., Hamidou Z., Fiteni F., Bonnetain F., Woronoff-Lemsi M.-C, Bascoul-Mollevi C. et al..  2020.  Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review. QUALITY OF LIFE RESEARCH. 29:867-878.
Quoix E, Westeel V.  2018.  Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma? JOURNAL OF THORACIC DISEASE. 10:S3043-S3046.
Cottone F, Collins GS, Anota A, Sommer K, Giesinger JM, Kieffer JM, Aaronson NK, Van Steen K, Charton E, Castagnetti F et al..  2020.  Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapies. JOURNAL OF CLINICAL EPIDEMIOLOGY. 127:9-18.
Anota A, Hamidou Z, Paget-Bailly S, Chibaudel B, Bascoul-Mollevi C, Auquier P, Westeel V, Fiteni F, Borg C, Bonnetain F.  2015.  Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization? QUALITY OF LIFE RESEARCH. 24:5-18.
Charton E, Anota A, Bonnetain F, Winters ZE.  2017.  Time to health-related quality of life score deterioration at 1-year follow-up after immediate latissimus dorsi breast reconstructions: a prospective study in breast cancer. QUALITY OF LIFE RESEARCH. 26:41.
Charton E, Efficace F, Cottone F, Touraine C, Cuer B, Hamidou Z, Fiteni F, Bonnetain F, Bascoul-Mollevi C, Anota A.  2018.  Time to health-related quality of life score deterioration in oncology phase III clinical trials: a systematic review. QUALITY OF LIFE RESEARCH. 27:S34-S35.
Charton E, Efficace F, Cottone F, Touraine C, Cuer B, Hamidou Z, Fiteni F, Bonnetain F, Bascoul-Mollevi C, Anota A.  2018.  Time to health-related quality of life score deterioration in oncology phase III clinical trials: a systematic review. QUALITY OF LIFE RESEARCH. 27:S34-S35.
Cottone F, Anota A, Bonnetain F, Efficace F.  2017.  Time to quality of life improvement as a method for longitudinal analysis of treatment efficacy. QUALITY OF LIFE RESEARCH. 26:37-38.
Demarquette H, Guider S, Jurczyszyn AJ, Caillot D, Pegourie B, Chretien MLorraine, Lancesseur C, Karlin L, Joao CM, Bories C et al..  2015.  Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma (eNDMM) from Thalidomide. BLOOD. 126
Caillot D, Newingerm M, Macro M, Pegourie B, Karlin L, Gay F, Bories C, Legros L, Garderet L, Ikhlef S et al..  2014.  Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma from Thalidomide. BLOOD. 124
Caillot D, Newingerm M, Macro M, Pegourie B, Karlin L, Gay F, Bories C, Legros L, Garderet L, Ikhlef S et al..  2014.  Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma from Thalidomide. BLOOD. 124
Goetghebuer T, Hainaut M, Van der Kelen E, Delforge M, Warszawski J, Le Chenadec J, Ramos E, Dialla O, Wack T, Laurent C et al..  2018.  Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand. CLINICAL INFECTIOUS DISEASES. 66:594-603.
Colonna M., Boussari O., Cowppli-Bony A., Delafosse P., Romain G., Grosclaude P., Jooste V, FRA FNetwork Ca.  2018.  Time trends and short term projections of cancer prevalence in France. CANCER EPIDEMIOLOGY. 56:97-105.
Colonna M., Boussari O., Cowppli-Bony A., Delafosse P., Romain G., Grosclaude P., Jooste V., FR FNetwork Ca.  2018.  Time trends and short term projections of cancer prevalence in France (vol 56, pg 97, 2018). CANCER EPIDEMIOLOGY. 57:158-159.
Gabet A., De Peretti C., Woimant F., Giroud M., Bejot Y., Schnitzler A., Olie V..  2017.  Time trends in admissions in follow-up care and rehabilitation units after stroke in France-2010-2014. CEREBROVASCULAR DISEASES. 43
Gabet A., De Peretti C., Woimant F., Giroud M., Bejot Y., Schnitzler A., Olie V..  2017.  Time trends in admissions in follow-up care and rehabilitation units after stroke in France-2010-2014. CEREBROVASCULAR DISEASES. 43
Yiin GSC, Li L, Bejot Y, Rothwell PM.  2019.  Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review. STROKE. 50:21-27.
Manfredi S, Jooste V, Gay C, Faivre J, Drouillard A, Bouvier A-M.  2017.  Time trends in colorectal cancer early postoperative mortality. A French 25-year population-based study. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 32:1725-1731.
Morgant M-C, Pages P-B, Orsini B, Falcoz P-E, Thomas P-A, Barthes FLe Pimpec, Dahan M, Bernard A, Soc EProject Fr.  2015.  Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study. EUROPEAN RESPIRATORY JOURNAL. 46:1131-1139.
Bonnard B, Henninger HC, Nemcova J, Pomet J-B.  2015.  Time Versus Energy in the Averaged Optimal Coplanar Kepler Transfer Towards Circular Orbits. ACTA APPLICANDAE MATHEMATICAE. 135:47-80.
Gacon P.H.  2017.  Time vortex formation in a experimental heart failure rat model as an index of mortality.. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING. 16:S68-S69.
Gacon P.H.  2017.  Time vortex formation in a experimental heart failure rat model as an index of mortality.. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING. 16:S68-S69.

Pages